title: Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway.
abstract: A family of extremely reactive electrophiles, isolevuglandins (isoLGs), is generated in vivo by free radical-induced lipid oxidation and rearrangement of endoperoxide intermediates of the isoprostane pathway. Protein adducts of two different oxidized lipids, isoLGE(2) and iso[4]LGE(2), and the corresponding autoantibodies are present in human blood. Western blot analysis of a polyacrylamide gel electrophoresis gel detects several immunoreactive plasma proteins. Only a minor fraction of the isoLG-protein modifications is associated with low density lipoprotein since mean levels were decreased only 20-22% by immunoprecipitation of apolipoprotein B (apoB). Mean levels of both isoLGE(2) and iso[4]LGE(2)-protein adducts in plasma from patients with atherosclerosis (AS) (n=16) or end-stage renal disease (RD) (n=8) are about twice those in healthy individuals (n=25). These elevated levels are not related to variations in age, total cholesterol or apoB. A linear correlation (r=0.79) between plasma isoLGE(2) and iso[4]LGE(2)-protein adduct levels in all 49 individuals is consistent with a common free radical-induced mechanism for the production of both oxidized lipids in vivo. The correlation is even stronger (r=0.86) for patients with AS or RD. That isoLG-protein adduct levels are more strongly correlated with disease than are total cholesterol or apoB suggests an independent defect that results in an abnormally high level of oxidative injury associated with AS and RD.
authors.affiliation: Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106-7078, USA. rgs@po.cwru.edu
authors.forename: R G
authors.initials: RG
authors.lastname: Salomon
authors.forename: E
authors.initials: E
authors.lastname: Batyreva
authors.forename: K
authors.initials: K
authors.lastname: Kaur
authors.forename: D L
authors.initials: DL
authors.lastname: Sprecher
authors.forename: M J
authors.initials: MJ
authors.lastname: Schreiber
authors.forename: J W
authors.initials: JW
authors.lastname: Crabb
authors.forename: M S
authors.initials: MS
authors.lastname: Penn
authors.forename: A M
authors.initials: AM
authors.lastname: DiCorletoe
authors.forename: S L
authors.initials: SL
authors.lastname: Hazen
authors.forename: E A
authors.initials: EA
authors.lastname: Podrez
mesh_terms: D000328:Adult; D000818:Animals; D001055:Apolipoproteins B / Q000378:metabolism; D001161:Arteriosclerosis / Q000097:blood; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D002784:Cholesterol / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D005609:Free Radicals; D006433:Hemocyanins / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood; D050356:Lipid Metabolism; D008875:Middle Aged; D015394:Molecular Structure; D010084:Oxidation-Reduction; D044262:Prostaglandin H2; D011458:Prostaglandins E / Q000097:blood / Q000378:metabolism*; D011463:Prostaglandins H / Q000378:metabolism*; D011817:Rabbits; D013237:Stereoisomerism
chemical_list: D001055:Apolipoproteins B; D001323:Autoantibodies; D005231:Fatty Acids, Unsaturated; D005609:Free Radicals; D011458:Prostaglandins E; D011463:Prostaglandins H; C526910:iso(4)levuglandin E2; D044262:Prostaglandin H2; D006433:Hemocyanins; C047684:levuglandin E2; D002784:Cholesterol; C032808:keyhole-limpet hemocyanin